Study Stopped
Paused due to change in staffing arrangements
CBT for Problematic Impulsive Behaviours in Bipolar Disorder: A Case Series / CBT-PIB
CBT for Mood-Driven, Problematic, Impulsive Behaviours in Bipolar Disorder: A Case Series Evaluation
1 other identifier
interventional
10
1 country
1
Brief Summary
The goal of this case series is to explore whether a talking therapy, specifically Cognitive Behavioural Therapy (CBT) is acceptable and feasible in the management of mood-driven impulsive behaviours in people with bipolar disorder (BD). The main questions it aims to answer are:
- Whether CBT Is a feasible intervention for participants with BD who report mood-driven, problematic impulsive behaviours.
- Whether CBT for mood-driven, problematic impulsive behaviours (CBT-PIB) is acceptable to service users with BD and therapists.
- Whether clinical outcomes are consistent with the potential for this novel intervention to offer clinical benefit to participants with BD. The study also hopes to:
- conduct a preliminary examination of the safety of CBT-PIB and the research procedures.
- gather information on the potential mechanisms of action of CBT-PIB and,
- gather information on the types of mood-driven impulsive behaviours individuals with BD may seek support for. Participants will:
- be offered up to 12 individual sessions of CBT focusing on mood-driven impulsive behaviours.
- be asked to complete a battery of self-report measures (5) when they enter the study and at the start and end of treatment.
- be asked to track mood and impulsive behaviours by completing a brief set of measures (3) weekly during the two-week baseline phase, the intervention phase and the 2-week post-intervention phase.
- be asked to complete a survey on the acceptability of the intervention and
- be invited to an optional semi-structured interview on their research experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 17, 2023
CompletedFirst Submitted
Initial submission to the registry
October 26, 2023
CompletedFirst Posted
Study publicly available on registry
November 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 24, 2027
April 30, 2025
April 1, 2025
3.1 years
October 26, 2023
April 25, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Overall acceptability and feasibility of the CBT protocol measured by the Client Satisfaction Questionnaire CBT-PIB
qualitative and quantitative feedback from participants
Post-intervention at week 16
rates of clinically significant and reliable change in mood measured by the Patient health questionnaire (PHQ-9)
used to monitor the severity of depression and response to treatment
Through study completion, an average of 18 weeks
rates of clinically significant and reliable change in symptoms of mania measured by the Altman Self-Rating Mania Scale
scale that assesses the presence and severity of manic or hypomanic symptoms
Through study completion, an average of 18 weeks
Changes in management of impulsivity measured by the Visual Analogue Scale
Visual scale measuring the severity and impact of general and behavioural impulsivity
Through study completion, an average of 18 weeks
Number of participants with intervention-related adverse events assessed by the adverse events form
qualitative form eliciting adverse events
Through study completion, an average of 18 weeks
Secondary Outcomes (5)
rates of clinically significant and reliable change in general daily functioning as measured by the Work and Social Adjustment Scale
At baseline, 2 weeks and 14 weeks
rates of clinically significant and reliable change in quality of life as measured by the Brief Quality of Life in Bipolar Disorder
At baseline, 2 weeks and 14 weeks
rates of clinically significant and reliable change in symptoms of anxiety as measured by the General Anxiety Disorder Assessment (GAD7)
At baseline, in 2 weeks and in 14 weeks
rates of clinically significant and reliable change in overall wellbeing as measured by the Warwick-Edinburgh Mental Well-being Scale
At baseline, in 2 weeks and in 14 weeks
rates of clinically significant and reliable change in impulsivity measured by the Short Urgency, Premeditation (lack of), Perseverance (lack of), Sensation Seeking, Positive Urgency, Impulsive Behavior Scale
At baseline, in 2 weeks and in 14 weeks
Study Arms (1)
CBT for mood driven, problematic, impulsive behaviours
EXPERIMENTALAll participants will be offered the 12 week CBT intervention
Interventions
Up to 12 sessions of Cognitive Behavioural Therapy adapted to focus on mood-driven impulsivity in adults with bipolar disorder.
Eligibility Criteria
You may qualify if:
- meeting diagnostic criteria for Bipolar I or II Disorder (SCID-5- Structured clinical interview for depression )
- able to identify at least one impulsive, problematic behaviour to target during the intervention;
- participants will require working knowledge of written and spoken English, sufficient to be able to make use of therapy and to be able complete research assessments without the need of a translator.
You may not qualify if:
- major depressive episode (identified through SCID-DSM-5);
- current experience of mania;
- current/past learning disability (IQ of less than 70 with impairment of social and adaptive functioning)
- organic brain change or substance dependence (drugs and alcohol) that would compromise ability to use therapy;
- current marked risk to self (i.e. self-harm or suicide) that we deem could not be appropriately managed in by the therapy site;
- currently lacking capacity to give informed consent;
- currently receiving other psychosocial therapy for impulsivity or bipolar disorder;
- current engagement in another psychological intervention addressing bipolar disorder or impulsivity;
- presence of another area of difficulty that the therapist and client believe should be the primary focus of intervention (for example, Post-Traumatic Stress Disorder, psychosis).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Exeterlead
- Southern Health NHS Foundation Trustcollaborator
- Somerset NHS Foundation Trustcollaborator
- Devon Partnership NHS Trustcollaborator
Study Sites (1)
AccEPT Clinic
Exeter, Devon, EX4 4QG, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jan Freeman, MSc
University of Exeter
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2023
First Posted
November 13, 2023
Study Start
August 17, 2023
Primary Completion (Estimated)
September 10, 2026
Study Completion (Estimated)
January 24, 2027
Last Updated
April 30, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Access will be possible from date of publication.
- Access Criteria
- The research database will be registered with the University of Exeter public access database. The dataset will be anonymous and will be registered with a metadata only record, allowing the research team to control access to the dataset, restricting it to appropriately qualified third parties.
All data that underlie results in a publication.